1. Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease
   Yan Wang et al, 2023, Frontiers in Immunology CrossRef
2. Pharmacological Actions, Molecular Mechanisms, Pharmacokinetic Progressions, and Clinical Applications of Hydroxysafflor Yellow A in Antidiabetic Research
   Xilan Zhang et al, 2021, Journal of Immunology Research CrossRef
3. Inhibition of Bruton’s Tyrosine Kinase Activity Attenuates Hemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats
   Nikita M. Patel et al, 2023, Annals of Surgery CrossRef
4. Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota
   Yinhua Ni et al, 2022, Acta Biochimica et Biophysica Sinica CrossRef
5. Expression of USP25 associates with fibrosis, inflammation and metabolism changes in IgG4-related disease
   Panpan Jiang et al, 2024, Nature Communications CrossRef
6. Unveiling FOS as a Potential Diagnostic Biomarker and Emetine as a Prospective Therapeutic Agent for Diabetic Nephropathy
   Jiaqiong Lin et al, 2023, Journal of Inflammation Research CrossRef
7. Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease
   Da-Wei Lin et al, 2024, International Journal of Molecular Sciences CrossRef
8. Roles and crosstalks of macrophages in diabetic nephropathy
   Hai-Di Li et al, 2022, Frontiers in Immunology CrossRef
9. Using digital pathology to analyze the murine cerebrovasculature
   Dana M Niedowicz et al, 2024, Journal of Cerebral Blood Flow & Metabolism CrossRef
10. Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials
    Dariusz Rozkiewicz et al, 2023, Molecules CrossRef